Bosun Asset Management’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
NTCM
CCM
Bosun Asset Management's IRMD Position: Q3 2025 in Review
Bosun Asset Management sold out of iRadimed (IRMD) in Q3 2025, closing a stake of 24,889 shares — an estimated $1.49M sold.
Bosun Asset Management first reported a position in IRMD in Q3 2024 and held it in 4 quarters. The position peaked at $1.49M in Q2 2025. 185 funds tracked by Wall St. Rank hold IRMD as of Q3 2025.
- Bosun Asset Management reported no remaining iRadimed position as of Q3 2025 after selling out during the quarter.
- Bosun Asset Management sold 24,889 iRadimed shares in Q3 2025, an estimated $1.49M.
- Bosun Asset Management first reported a position in iRadimed in Q3 2024 and held it in 4 quarters.
- Bosun Asset Management's iRadimed position peaked at $1.49M in Q2 2025.
- 185 funds tracked by Wall St. Rank held iRadimed as of Q3 2025.
Based on Bosun Asset Management's 13F filing for Q3 2025, filed 10 Nov 2025.